FI922737A0 - Foerbaettrad meningococcalpolysackarid konjugatvaccin. - Google Patents

Foerbaettrad meningococcalpolysackarid konjugatvaccin.

Info

Publication number
FI922737A0
FI922737A0 FI922737A FI922737A FI922737A0 FI 922737 A0 FI922737 A0 FI 922737A0 FI 922737 A FI922737 A FI 922737A FI 922737 A FI922737 A FI 922737A FI 922737 A0 FI922737 A0 FI 922737A0
Authority
FI
Finland
Prior art keywords
meningococcalpolysackarid
konjugatvaccin
foerbaettrad
meningococcalpolysackarid konjugatvaccin
foerbaettrad meningococcalpolysackarid
Prior art date
Application number
FI922737A
Other languages
English (en)
Other versions
FI104539B (fi
Inventor
Harold J Jennings
Francis Michon
Original Assignee
Ca Nat Research Council
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ca Nat Research Council filed Critical Ca Nat Research Council
Publication of FI922737A0 publication Critical patent/FI922737A0/fi
Application granted granted Critical
Publication of FI104539B publication Critical patent/FI104539B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
    • C07K16/1228—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K16/1232—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia from Escherichia (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0258—Escherichia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/095—Neisseria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
    • C07K16/1217—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Neisseriaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6037—Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
FI922737A 1989-12-14 1992-06-12 Menetelmä muunnellun Neisseria meningitidis ryhmä B polysakkaridin tai muunnellun E. coli K1 kotelomaisen polysakkaridin valmistamiseksi FI104539B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US44819589A 1989-12-14 1989-12-14
US44819589 1989-12-14
CA9000437 1990-12-13
PCT/CA1990/000437 WO1991008772A1 (en) 1989-12-14 1990-12-13 Improved meningococcal polysaccharide conjugate vaccine

Publications (2)

Publication Number Publication Date
FI922737A0 true FI922737A0 (fi) 1992-06-12
FI104539B FI104539B (fi) 2000-02-29

Family

ID=23779371

Family Applications (2)

Application Number Title Priority Date Filing Date
FI922737A FI104539B (fi) 1989-12-14 1992-06-12 Menetelmä muunnellun Neisseria meningitidis ryhmä B polysakkaridin tai muunnellun E. coli K1 kotelomaisen polysakkaridin valmistamiseksi
FI991917A FI19991917A (fi) 1989-12-14 1999-09-09 Parannettu meningokokki-polysakkaridikonjugaattirokote

Family Applications After (1)

Application Number Title Priority Date Filing Date
FI991917A FI19991917A (fi) 1989-12-14 1999-09-09 Parannettu meningokokki-polysakkaridikonjugaattirokote

Country Status (30)

Country Link
US (3) US5576002A (fi)
EP (1) EP0504202B1 (fi)
JP (1) JP2637845B2 (fi)
KR (1) KR0158436B1 (fi)
CN (4) CN1049223C (fi)
AR (1) AR243934A1 (fi)
AT (1) ATE121947T1 (fi)
AU (1) AU641715B2 (fi)
BR (1) BR9007917A (fi)
CA (1) CA2071811C (fi)
CZ (1) CZ283530B6 (fi)
DE (1) DE69019164T2 (fi)
DK (1) DK0504202T3 (fi)
ES (1) ES2071288T3 (fi)
FI (2) FI104539B (fi)
HR (1) HRP920872A2 (fi)
HU (2) HU9201966D0 (fi)
IE (1) IE68414B1 (fi)
IL (1) IL96676A (fi)
IN (1) IN171747B (fi)
NO (2) NO305275B1 (fi)
NZ (1) NZ236471A (fi)
PH (1) PH30305A (fi)
PL (2) PL166659B1 (fi)
RO (1) RO111416B1 (fi)
RU (1) RU2105568C1 (fi)
SI (1) SI20008B (fi)
WO (1) WO1991008772A1 (fi)
YU (1) YU24391A (fi)
ZA (1) ZA9010065B (fi)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5648241A (en) 1989-09-15 1997-07-15 The General Hospital Corporation Conjugate vaccine against group B streptococcus
RO111416B1 (ro) * 1989-12-14 1996-10-31 Ca Nat Research Council Polizaharide modificate de neisseria meningitidis si e coli, combinatii antigenice si metoda de imunizare
CA2145397C (en) * 1992-09-24 2007-10-30 Harold J. Jennings Group b streptococcus type ii and type v polysaccharide-protein conjugate vaccines
US6153406A (en) * 1993-07-23 2000-11-28 North American Vaccine, Inc. Method for the high level expression, purification and refolding of the outer membrane protein P2 from Haemophilus influenzae type B
US5439808A (en) * 1993-07-23 1995-08-08 North American Vaccine, Inc. Method for the high level expression, purification and refolding of the outer membrane group B porin proteins from Neisseria meningitidis
US5700787A (en) * 1994-09-02 1997-12-23 Brigham & Women's Hospital, Inc. Capsular polysaccharide immunomodulator
US5679654A (en) * 1994-09-02 1997-10-21 Brigham & Women's Hospital, Inc. Capsular polysaccharide immunomodulator
US5747287A (en) * 1995-04-28 1998-05-05 North American Vaccine, Inc. Method for the high level expression, purification and refolding of the outer membrane group B porin proteins from Neisseria meningitidis
DK1090642T3 (da) * 1995-06-07 2008-09-22 Glaxosmithkline Biolog Sa Vacciner omfattende et polysaccharidantigen-bæreprotein-konjugat og frit bæreprotein
US6284884B1 (en) 1995-06-07 2001-09-04 North American Vaccine, Inc. Antigenic group B streptococcus type II and type III polysaccharide fragments having a 2,5-anhydro-D-mannose terminal structure and conjugate vaccine thereof
US5811102A (en) 1995-06-07 1998-09-22 National Research Council Of Canada Modified meningococcal polysaccharide conjugate vaccines
ZA97248B (en) * 1996-01-18 1997-07-18 Rohm & Haas Method for identifying and quantifying polymers utilizing immunoassay techniques
CA2264585C (en) 1996-08-27 2005-06-14 Chiron Corporation Monoclonal antibodies that define unique meningococcal b epitopes and their use in the preparation of vaccine compositions
DK0939647T4 (da) 1996-08-27 2006-10-23 Novartis Vaccines & Diagnostic Neisseria Meningitidis-serogruppe B-glycokonjugat og fremgangsmåde til anvendelse deraf
US6426074B1 (en) 1997-03-19 2002-07-30 The Brigham And Women's Hospital Inc. Group B Streptococcus vaccine
JP2002506448A (ja) 1997-06-24 2002-02-26 カイロン コーポレイション 抗髄膜炎菌ワクチン組成物を使用して成体を免疫する方法
AU9120898A (en) * 1997-08-27 1999-03-16 Chiron Corporation Molecular mimetics of meningococcal b epitopes
ES2346022T3 (es) 1997-12-23 2010-10-07 Baxter Healthcare S.A. Procedimiento para la extraccion y el aislamiento de polisacaridos capsulares bacterianos para su uso como vacunas o ligandos a proteinas como vacunas de conjugados.
DE69941574D1 (de) * 1998-08-19 2009-12-03 Baxter Healthcare Sa Immunogenes beta-propionamido-gebundenes polysaccharid-protein konjugat geeignet als impfstoff und hergestellt bei verwendung von n-acryloyliertem polysaccharid
US6436653B1 (en) 1998-12-15 2002-08-20 Exiqon A/S Method for introduction of reporter groups into bacterial lipopolysaccharide-derived carbohydrates and the subsequent coupling of such derivatives onto solid surfaces
US7083777B1 (en) * 1999-04-02 2006-08-01 The Brigham And Women's Hospital, Inc. Immunomodulating polymers
US6518037B2 (en) * 1999-11-12 2003-02-11 University Of Iowa Research Foundation Two-component system that controls bacterial membrane synthesis
GB9928196D0 (en) * 1999-11-29 2000-01-26 Chiron Spa Combinations of B, C and other antigens
SV2003000753A (es) 2000-12-05 2003-06-16 Brigham & Womens Hospital Uso de polisacaridos zwitterionicos para la especifica modulacion del progreso inmunologico
JP2004529643A (ja) 2001-04-17 2004-09-30 カイロン コーポレイション 機能活性抗体を誘発する髄膜炎菌性ｂエピトープの分子模倣物
GB0115176D0 (en) * 2001-06-20 2001-08-15 Chiron Spa Capular polysaccharide solubilisation and combination vaccines
GB0121591D0 (en) * 2001-09-06 2001-10-24 Chiron Spa Hybrid and tandem expression of neisserial proteins
AR045702A1 (es) 2001-10-03 2005-11-09 Chiron Corp Composiciones de adyuvantes.
ES2616180T3 (es) * 2002-03-26 2017-06-09 Glaxosmithkline Biologicals Sa Sacáridos modificados con estabilidad mejorada en agua para su uso como medicamento
US20040219160A1 (en) * 2003-03-31 2004-11-04 The Brigham And Women's Hospital, Inc. Zwitterionic immunomodulators for the treatment of asthma and allergy
US7731967B2 (en) 2003-04-30 2010-06-08 Novartis Vaccines And Diagnostics, Inc. Compositions for inducing immune responses
JP4566194B2 (ja) * 2003-08-12 2010-10-20 リポクセン テクノロジーズ リミテッド タンパク質の誘導体化及び結合のためのシアル酸誘導体
US8148335B2 (en) 2004-06-23 2012-04-03 Children's Hospital & Research Center Oakland De-N-acetyl sialic acid antigens, antibodies thereto, and methods of use in cancer therapy
MXPA06015107A (es) 2004-06-23 2007-03-26 Childrens Hosp & Res Ct Oak Derivados de polisacaridos y sus usos en la induccion de una respuesta inmune.
GB0428394D0 (en) * 2004-12-24 2005-02-02 Chiron Srl Saccharide conjugate vaccines
KR20130122810A (ko) 2005-06-27 2013-11-08 글락소스미스클라인 바이오로지칼즈 에스.에이. 백신 제조 방법
WO2007092451A2 (en) 2006-02-06 2007-08-16 The Brigham And Women's Hospital, Inc. Zwitterionic polysaccharides for promotion of immune system maturation and health
GB0611914D0 (en) 2006-06-15 2006-07-26 Teti Giuseppe Peptides that mimic non-human cross-reactive protective epitopes of the group Bmeningococcal capsulsar polysaccharide
EP1872791A1 (en) * 2006-06-30 2008-01-02 Institut Pasteur Use of bacterial polysaccharides for biofilm inhibition
AU2008265767B2 (en) * 2007-06-20 2014-11-13 Pfizer Ireland Pharmaceuticals Modified polysaccharides for conjugate vaccines
ES2664753T3 (es) 2007-12-07 2018-04-23 Glaxosmithkline Biologicals Sa Composiciones de inducción de respuestas inmunes
US9050283B2 (en) 2009-01-16 2015-06-09 University Of Maryland, Baltimore Broad spectrum vaccine against non-typhoidal Salmonella
WO2013009945A1 (en) 2011-07-12 2013-01-17 The Brigham And Women's Hospital, Inc. Lipid-containing psa compositions, methods of isolation and methods of use thereof
EP2752403A1 (de) * 2013-01-08 2014-07-09 Sika Technology AG Amin für emissionsarme Epoxidharz-Produkte
JP6918365B2 (ja) 2015-08-19 2021-08-11 プレジデント アンド フェローズ オブ ハーバード カレッジ 脂質化ｐｓａ組成物および方法
WO2018014012A1 (en) 2016-07-15 2018-01-18 President And Fellows Of Harvard College Glycolipid compositions and methods of use
SG11201906519RA (en) * 2017-01-31 2019-08-27 Pfizer Neisseria meningitidis compositions and methods thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4057685A (en) * 1972-02-02 1977-11-08 Abbott Laboratories Chemically modified endotoxin immunizing agent
US4356170A (en) * 1981-05-27 1982-10-26 Canadian Patents & Development Ltd. Immunogenic polysaccharide-protein conjugates
US4673574A (en) * 1981-08-31 1987-06-16 Anderson Porter W Immunogenic conjugates
US4619828A (en) * 1982-07-06 1986-10-28 Connaught Laboratories, Inc. Polysaccharide exotoxoid conjugate vaccines
US4496538A (en) * 1982-07-06 1985-01-29 Connaught Laboratories, Inc. Haemophilus influenzae b polysaccharide-diphtheria toxoid conjugate vaccine
US4644059A (en) * 1982-07-06 1987-02-17 Connaught Laboratories, Inc. Haemophilus influenzae B polysaccharide-diptheria toxoid conjugate vaccine
US4695624A (en) * 1984-05-10 1987-09-22 Merck & Co., Inc. Covalently-modified polyanionic bacterial polysaccharides, stable covalent conjugates of such polysaccharides and immunogenic proteins with bigeneric spacers, and methods of preparing such polysaccharides and conjugates and of confirming covalency
US4727136A (en) * 1985-10-01 1988-02-23 Canadian Patents And Development Ltd. Modified meningococcal group B polysaccharide for conjugate vaccine
RO111416B1 (ro) * 1989-12-14 1996-10-31 Ca Nat Research Council Polizaharide modificate de neisseria meningitidis si e coli, combinatii antigenice si metoda de imunizare

Also Published As

Publication number Publication date
US5576002A (en) 1996-11-19
IE68414B1 (en) 1996-06-12
NZ236471A (en) 1992-10-28
NO922316D0 (no) 1992-06-12
FI104539B (fi) 2000-02-29
CZ628490A3 (en) 1997-12-17
KR0158436B1 (ko) 1998-12-01
AU641715B2 (en) 1993-09-30
CN1072506C (zh) 2001-10-10
DK0504202T3 (da) 1995-10-02
CN1100428A (zh) 1995-03-22
NO305275B1 (no) 1999-05-03
NO973311L (no) 1992-08-14
CN1096516A (zh) 1994-12-21
PH30305A (en) 1997-02-20
RU2105568C1 (ru) 1998-02-27
IL96676A (en) 1996-09-12
US5683699A (en) 1997-11-04
NO307835B1 (no) 2000-06-05
HU9201966D0 (en) 1992-10-28
PL288271A1 (en) 1991-12-16
SI20008A (sl) 2000-02-29
HUT64480A (en) 1994-01-28
CN1036504C (zh) 1997-11-26
JP2637845B2 (ja) 1997-08-06
YU24391A (sh) 1995-12-04
RO111416B1 (ro) 1996-10-31
FI19991917A (fi) 1999-09-09
HRP920872A2 (en) 1997-06-30
CN1036522C (zh) 1997-11-26
CA2071811A1 (en) 1991-06-15
CN1055541A (zh) 1991-10-23
CZ283530B6 (cs) 1998-04-15
IE904513A1 (en) 1991-06-19
US5902586A (en) 1999-05-11
AR243934A1 (es) 1993-09-30
WO1991008772A1 (en) 1991-06-27
EP0504202B1 (en) 1995-05-03
NO922316L (no) 1992-08-14
DE69019164D1 (de) 1995-06-08
IL96676A0 (en) 1991-09-16
NO973311D0 (no) 1997-07-17
SI20008B (en) 2001-02-28
CN1100656A (zh) 1995-03-29
ATE121947T1 (de) 1995-05-15
CA2071811C (en) 2003-11-04
ZA9010065B (en) 1992-02-26
PL166659B1 (pl) 1995-06-30
JPH05505392A (ja) 1993-08-12
IN171747B (fi) 1992-12-26
PL166035B1 (pl) 1995-03-31
EP0504202A1 (en) 1992-09-23
HU218146B (hu) 2000-06-28
ES2071288T3 (es) 1995-06-16
BR9007917A (pt) 1992-10-20
CN1049223C (zh) 2000-02-09
DE69019164T2 (de) 1995-09-07
AU6898791A (en) 1991-07-18

Similar Documents

Publication Publication Date Title
FI922737A0 (fi) Foerbaettrad meningococcalpolysackarid konjugatvaccin.
FI902584A0 (fi) Korrosionsbestaendigt skyddsskal foer kaernbraenslestavar.
FI904360A0 (fi) Aminosyraderivat.
NO903905L (no) Smartkort-holder.
FI906360A (fi) Sulfonylurea- och ograesbekaempningsmedel innehaollande skyddsblandningar.
FI906357A0 (fi) Engaongsinjektionsspruta.
DE59004522D1 (de) Mikrodosiergerät.
DE59005135D1 (de) Formstein.
FI891586A (fi) Elektrisk bastuugn.
FI906302A (fi) Belaeggningsfoerfarande.
FI906051A (fi) Malariavaccin.
FI905071A0 (fi) Lineaer vaexel.
FI903125A0 (fi) Katjoniska ytaktiva fibervaordskompositioner innefattande laongkedjiga kolvaetegrupper innehaollande foereningar.
FI906243A (fi) Vaermegivare.
FI906380A0 (fi) Sammansaettningar innehaollande etensampolymerer.
NO901259L (no) Fire-innretning.
FI892999A0 (fi) Traktor.
FI895584A0 (fi) Betonggjutform.
FI896253A0 (fi) Avstaengningsventil.
FI891254A0 (fi) Koppling foer likstroemomformare.
FI890855A (fi) Skidstavstruga.
DE59004564D1 (de) Mappe.
NO900675D0 (no) Sluk.
FI913334A0 (fi) Anordning foer spaenningsuttag.
ATE100755T1 (de) Brieflocher.